Trademark: 90083021
Status Date
Monday, September 26, 2022
Filing Date
Thursday, July 30, 2020
Published for Opposition
Tuesday, December 29, 2020
Abandoned Date
Monday, September 26, 2022
5 Pharmaceutical products for the treatment of inflammatory diseases, fibrotic diseases, systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis
Sep 26, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 26, 2022
Abandonment - No Use Statement Filed
Feb 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2022
Sou Extension 2 Granted
Feb 23, 2022
Sou Extension 2 Filed
Feb 23, 2022
Teas Extension Received
Aug 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2021
Sou Extension 1 Granted
Aug 10, 2021
Sou Extension 1 Filed
Aug 10, 2021
Teas Extension Received
Feb 23, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 29, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 29, 2020
Published For Opposition
Dec 9, 2020
Notification Of Notice Of Publication E-Mailed
Nov 20, 2020
Approved For Pub - Principal Register
Nov 18, 2020
Assigned To Examiner
Aug 28, 2020
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
